Learn what zavegepant is, how this intranasal CGRP receptor antagonist works for acute migraine treatment, and why its non‑vasoconstrictive, needle‑free nasal spray delivery may benefit patients with nausea or cardiovascular risk factors.
Learn what zavegepant is, how this intranasal CGRP receptor antagonist differs from traditional triptans, and review key clinical trial evidence on its speed, effectiveness, and safety for acute migraine treatment.